{"id":5261,"date":"2021-02-25T13:56:37","date_gmt":"2021-02-25T12:56:37","guid":{"rendered":"https:\/\/staybletherapeutics.com\/sv\/?p=5261"},"modified":"2021-02-25T13:56:37","modified_gmt":"2021-02-25T12:56:37","slug":"inside-stayble-februari-2021","status":"publish","type":"post","link":"https:\/\/staybletherapeutics.com\/sv\/presentationer\/inside-stayble-februari-2021\/","title":{"rendered":"Inside Stayble: Februari 2021"},"content":{"rendered":"<p><span style=\"color: #333333;\">I februari 2021 uppdateringen reflekterar VD Andreas Gerward \u00f6ver det positiva utfallet kring bolagets f\u00f6retr\u00e4desemission samt ger en \u00f6versikt kring kommande partneringdiskussioner<br \/>\nInside Stayble \u00e4r en kommunikationskanal f\u00f6r att ge aktie\u00e4gare m\u00e5nadsvisa uppdateringar om Stayble Therapeutics och det kliniska utvecklingsprogrammet f\u00f6r STA363 i kronisk l\u00e4ndryggssm\u00e4rta.<br \/>\n<\/span><\/p>\n<p><span style=\"color: #333333;\">Stayble Therapeutics \u00e4r listat p\u00e5 Nasdaq First North (STABL).<\/span><\/p>\n<p><span style=\"color: #333333;\">L\u00e4s mer p\u00e5\u00a0<\/span><a href=\"http:\/\/staybletherapeutics.se\/\"><span style=\"color: #0563c1;\">staybletherapeutics.se<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>I februari 2021 uppdateringen reflekterar VD Andreas Gerward \u00f6ver det positiva utfallet kring bolagets f\u00f6retr\u00e4desemission samt ger en \u00f6versikt kring kommande partneringdiskussioner Inside Stayble \u00e4r en kommunikationskanal f\u00f6r att ge&#8230;<\/p>\n","protected":false},"author":1,"featured_media":5178,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/posts\/5261"}],"collection":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/comments?post=5261"}],"version-history":[{"count":2,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/posts\/5261\/revisions"}],"predecessor-version":[{"id":5264,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/posts\/5261\/revisions\/5264"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/media\/5178"}],"wp:attachment":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/media?parent=5261"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/categories?post=5261"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/tags?post=5261"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}